MEAGAN LAMBERT: Open Payments
NPI 1235639311 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,718 in 41 payments from 12 companies in 2025. Trend: 2023 $944 · 2024 $1,730 · 2025 $1,718
Food & beverage: $982Consulting: $736
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $736 |
| Novartis Pharmaceuticals Corporation | 13 | $323 |
| Amgen Inc. | 9 | $154 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $133 |
| Janssen Biotech, Inc. | 4 | $106 |
| PFIZER INC. | 5 | $103 |
| UCB, Inc. | 3 | $78 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Organon LLC | 1 | $16 |
| GENZYME CORPORATION | 1 | $16 |
Products named: COSENTYX, TREMFYA, XELJANZ, Bimzelx, OTEZLA, TAVNEOS, EVENITY, SAPHNELO.
Industry payments across NC — which companies pay providers there.
